Martin E. Schmieg, COO/CFO
“C” level executive since 1992 leading startup and development stage companies Cytometrics, Inc., Advanced Bionics Corporation, SIRNA Therapeutics, Inc., lsolagen, Inc., Freedom-2, Inc., now Pharmacyte, Inc. and NeoStem, Inc. Early career experience with Boekel Scientific, Inc. and EM Diagnostic Systems, Inc., a division of E. Merck. Martin is a CPA and is also the founder and managing partner of Soar Ventures, a venture capital and strategic advisory firm.